Followers | 376 |
Posts | 17123 |
Boards Moderated | 4 |
Alias Born | 03/07/2014 |
![](https://investorshub.advfn.com/uicon/458287.png?cb=1657037051)
Tuesday, August 17, 2021 5:23:02 PM
GET OUT of this scam folks like escaping a nuclear holocaust !!
CELZ-a-FRAUD = 3 or 4 dudes in AZ as "the company" and they did $10K in THREE MONTHS aka $3K a month TOTAL REVENUES on the Qtr after diluting ONE BILLION SHARES since their last mega reverse split less than 2 short years ago !!
THEIR "SOLUTION" - DO ANOTHER MASSIVE REVERSE SPLIT at "no less than" a 1 for 100 WIPE OUT to common shareholders WTF holy cow this is B A D BAD !!
RUN n DUMP ASAP and at least get a tax write off from this POS SCAM before it's suspended or goes to shell status or whatever their end game is here- as they sure as HELL are NOT operating some sort of "legit medical research company using stem cells" blah blah BULLSHIT !!
TOXIC DEBT DILUTION MACHINE AND SHARE PRINTING MILL to self enrich 3 or 4 ass clowns in AZ is all this OTC con job is about - it's beyond the pale !!
DUMP NOW or be wiped out in ANOTHER 1 for 100 OR GREATER REVERSE SPLIT that can literally come ANY DAY NOW and ANY TIME with no further notice need be given as it's APPROVED AND IN THEIR "GUTTER FINANCE DEAL AGREEMENT" they just inked to FEED THE INSIDER BEAST !
https://www.sec.gov/Archives/edgar/data/1187953/000147793221005384/celz_ex41.htm
PAGE 6 DONE and SIGNED:
b) Reverse Stock Split. No later than 90 days following the Original Issue Date of this Note, the Company shall take all actions to effect a reverse stock split using a ratio of 1:100 or greater, including without limitation seeking shareholder approval, as required, and amending the charter documents of the Company.
"
THEE END :)
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.
Recent CELZ News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:10:25 PM
- Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program • GlobeNewswire Inc. • 07/24/2024 01:00:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • GlobeNewswire Inc. • 07/10/2024 12:30:00 PM
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM